AMPK activators and mTORC1 inhibitors |
|
Inhibitors of class I PI3K signaling |
CH5132799
GDC-0980
GDC-0941
|
Modulators of intracellular Ca2+
|
Fluspirilene
Verapamil
Loperamide
Amiodarone
Thapsigargin
|
Proteasome inhibitors |
Bortezomib
NPI-0052
MG-132
|
Histone deacetylase (HDACs) inhibitors |
|
Synthetic and plant-based chemotherapeutic agents |
|
Autophagy inhibitors |
Class III PI3K inhibitors blocks autophagy |
3-Methyladenine (3-MA)
Wortmannin
LY294002
Spautin
Vps34 inhibitors
|
Microtubule modulators |
Vinblastine
Nocodazole
Cytochalasin B and D
|
Lysosomal inhibitors |
Chloroquine (CQ)
Hydroxychloroquine (HCQ)
Quinacrine
Lys05, a dimeric CQ
Monensin
Lucanthone
Matrine
|
Vacuolar H+-ATPase inhibitors |
Bafilomycin A1
Concanamycin A
Azithromycin
|
Inhibitors of lysosomal hydrolases and proteases |
|
c-Jun N-terminal kinase (JNK) inhibitors |
|